Evelyn Herrmann
Papers
1
Total Citations
2
H-Index
1
About
Evelyn Herrmann is a leading researcher in the field of stereotactic radiosurgery and radiotherapy, with a primary focus on optimizing treatment planning for brain and liver tumors. Her work centers on the comparative analysis of advanced collimation technologies, particularly the InCise 2 multi leaf collimator (MLC) versus the IRIS variable aperture collimator on the CyberKnife Robotic Radiosurgery System. Her most cited study, "Dose analysis of InCise 2 multi leaf collimator and IRIS-based stereotactic radiotherapy plans for brain and liver tumors," provides critical insights into how second-generation MLC technology improves dose conformity and delivery efficiency for both small and large target volumes. This research has direct implications for enhancing patient outcomes by reducing treatment times and minimizing radiation exposure to healthy tissues. While her citation count is currently modest, Herrmann’s work represents a foundational contribution to the clinical adoption of next-generation radiosurgery platforms. Her meticulous dose parameter analyses help bridge the gap between technological innovation and practical clinical application, making her a valuable voice in the ongoing evolution of precision radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1